Table 1 Baseline characteristics of patients and visits in the pre-pandemic and pandemic periods
Pre-pandemic n = 23,279 | Pandemic n = 10,742 | Overall n = 34,021 | p-value | |
|---|---|---|---|---|
Patient characteristics | ||||
Mean age (SD) | 58.1 (18.9) | 58.1 (19.0) | 58.1 (18.9) | 0.99 |
Sex | 0.35 | |||
Female | 14,331 (61.6%) | 6556 (61.0%) | 20,887 (61.4%) | |
Male | 8948 (38.4%) | 4186 (39.0%) | 13,134 (38.6%) | |
Email registered | 11,650 (50.0%) | 6151 (57.3%) | 17,801 (52.3%) | < 0.0001 |
Visit characteristics | ||||
Visit type | < 0.0001 | |||
New consultation | 4007 (17.2%) | 1436 (13.4%) | 5443 (16.0%) | |
Follow-up | 19,272 (82.8%) | 9306 (86.6%) | 28,578 (84.0%) | |
Visit modality (grouped) | < 0.0001 | |||
In-person | 23,261 (99.9%) | 1943 (18.1%) | 25,204 (74.1%) | |
Virtual care | 18 (0.1%) | 8799 (81.9%) | 8817 (25.9%) | |
Visit modality (specified) | < 0.0001 | |||
In-person | 23,261 (99.9%) | 1943 (18.1%) | 25,204 (74.1%) | |
Telephone | 18 (0.1%) | 8388 (78.1%) | 8406 (24.7%) | |
Videoconference | 0 (0.0%) | 411 (3.8%) | 411 (1.2%) | |
Visit diagnosis | < 0.0001 | |||
AFib | 1797 (7.7%) | 590 (5.5%) | 2387 (7.0%) | |
CAD | 2097 (9.0%) | 898 (8.4%) | 2995 (8.8%) | |
CHF | 1319 (5.7%) | 752 (7.0%) | 2071 (6.1%) | |
HTN | 3285 (14.1%) | 1571 (14.6%) | 4856 (14.3%) | |
DM | 10,953 (47.1%) | 5088 (47.4%) | 16,041 (47.2%) | |
Asthma | 2732 (11.7%) | 1340 (12.5%) | 4072 (12.0%) | |
COPD | 1096 (4.7%) | 503 (4.7%) | 1599 (4.7%) | |
Clinic | < 0.0001 | |||
AACU | 1758 (7.6%) | 905 (8.4%) | 2663 (7.8%) | |
AFib clinic | 663 (2.8%) | 115 (1.1%) | 778 (2.3%) | |
Cardiology clinic | 6012 (25.8%) | 2768 (25.8%) | 8780 (25.8%) | |
GIM clinic | 655 (2.8%) | 248 (2.3%) | 903 (2.7%) | |
Endocrine clinic | 8070 (34.7%) | 3836 (35.7%) | 11,906 (35.0%) | |
DM clinic | 2428 (10.4%) | 1066 (9.9%) | 3494 (10.3%) | |
Respirology clinic | 3693 (15.9%) | 1804 (16.8%) | 5497 (16.2%) | |